Literature DB >> 17038119

An alpha-(1,4)-amylase is essential for alpha-(1,3)-glucan production and virulence in Histoplasma capsulatum.

Christopher L Marion1, Chad A Rappleye, Jacquelyn T Engle, William E Goldman.   

Abstract

Histoplasma capsulatum is a dimorphic fungus that causes respiratory and systemic disease and is capable of surviving and replicating within macrophages. The virulence of Histoplasma has been linked to cell wall alpha-(1,3)-glucan; however, the role of this polysaccharide during infection, its organization within the cell wall, and its synthesis and regulation remain poorly understood. To identify genes involved in the biosynthesis of alpha-(1,3)-glucan, we employed a forward genetics strategy to isolate physically marked mutants with reduced alpha-(1,3)-glucan. Insertional mutants were generated in a virulent strain of H. capsulatum by optimization of Agrobacterium tumefaciens-mediated transformation. Approximately 90% of these mutants possessed single insertions with no chromosomal rearrangements or deletions in the host genome. To confirm the role and specificity of identified candidate genes, we phenocopied the disrupted locus by either RNA interference or targeted gene deletion. Our findings indicate alpha-(1,3)-glucan production requires the function of the AMY1 gene product, a novel protein with homology to the alpha-amylase family of glycosyl hydrolases, and UGP1, a UTP-glucose-1-phosphate uridylyltransferase which synthesizes UDP-glucose monomers. Loss of AMY1 function attenuated the ability of Histoplasma to kill macrophages and to colonize murine lungs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17038119     DOI: 10.1111/j.1365-2958.2006.05436.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  54 in total

1.  The yeast-phase virulence requirement for α-glucan synthase differs among Histoplasma capsulatum chemotypes.

Authors:  Jessica A Edwards; Elizabeth A Alore; Chad A Rappleye
Journal:  Eukaryot Cell       Date:  2010-10-29

2.  Histoplasma capsulatum alpha-(1,3)-glucan blocks innate immune recognition by the beta-glucan receptor.

Authors:  Chad A Rappleye; Linda Groppe Eissenberg; William E Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

3.  Cryptococcus strains with different pathogenic potentials have diverse protein secretomes.

Authors:  Leona T Campbell; Anna R Simonin; Cuilan Chen; Jannatul Ferdous; Matthew P Padula; Elizabeth Harry; Markus Hofer; Iain L Campbell; Dee A Carter
Journal:  Eukaryot Cell       Date:  2015-04-03

Review 4.  α-Amylase: an enzyme specificity found in various families of glycoside hydrolases.

Authors:  Štefan Janeček; Birte Svensson; E Ann MacGregor
Journal:  Cell Mol Life Sci       Date:  2013-06-27       Impact factor: 9.261

Review 5.  Dimorphism and virulence in fungi.

Authors:  Bruce S Klein; Brad Tebbets
Journal:  Curr Opin Microbiol       Date:  2007-08-23       Impact factor: 7.934

6.  Expression of hygromycin phosphotransferase alters virulence of Histoplasma capsulatum.

Authors:  A George Smulian; Reta S Gibbons; Jeffery A Demland; Deborah T Spaulding; George S Deepe
Journal:  Eukaryot Cell       Date:  2007-09-14

7.  Redundant catalases detoxify phagocyte reactive oxygen and facilitate Histoplasma capsulatum pathogenesis.

Authors:  Eric D Holbrook; Katherine A Smolnycki; Brian H Youseff; Chad A Rappleye
Journal:  Infect Immun       Date:  2013-04-15       Impact factor: 3.441

Review 8.  Histoplasma capsulatum at the host-pathogen interface.

Authors:  Joshua D Nosanchuk; Attila Gacser
Journal:  Microbes Infect       Date:  2008-07-10       Impact factor: 2.700

9.  Insertional mutagenesis enables cleistothecial formation in a non-mating strain of Histoplasma capsulatum.

Authors:  Meggan C Laskowski; Alan G Smulian
Journal:  BMC Microbiol       Date:  2010-02-16       Impact factor: 3.605

10.  Reverse genetics through random mutagenesis in Histoplasma capsulatum.

Authors:  Brian H Youseff; Julie A Dougherty; Chad A Rappleye
Journal:  BMC Microbiol       Date:  2009-11-17       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.